PARP inhibitors as first-line maintenance therapy in ovarian cancer: recommendations from an expert panel from Brazil

To report consensus recommendations on the current role of poly(ADP-ribose) polymerase (PARP) inhibitors in the front-line management of patients with epithelial ovarian cancer (EOC) in the healthcare setting of Brazil. The expert panel convened in March 2021 and comprised 20 medical oncologists foc...

Descrición completa

Detalles Bibliográficos

Principais autores:	Aknar FC Calabrich, Daniele Xavier Assad, Graziela Dal-Molin, Andreia C Melo, Angelica Nogueira-Rodrigues, Karime Kalil, Andrea PG Guimarães, Michelle Samora Almeida, Carla Rameri de Azevedo, Daniela de Freitas, Alessandra Menezes Morelle, Ana Carolina Leite, Marcela Crosara, João Soares Nunes, Poliana Signorini, Eduardo Cronemberger, Rachel Cossetti, Rodrigo Guindalini, Eduardo Paulino, Fernando C Maluf
Formato:	Artigo
Idioma:	Inglês
Publicado:	Thieme Revinter Publicações Ltda. 2023-04-01
Series:	Brazilian Journal of Oncology
Assuntos:	carcinoma ovarian epithelial poly(adp-ribose) polymerase inhibitors consensus
Acceso en liña:	https://www.brazilianjournalofoncology.com.br/details/238/en-US/parp-inhibitors-as-first-line-maintenance-therapy-in-ovarian-cancer--recommendations-from-an-expert-panel-from-brazil
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!